Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation

International Journal of Artificial Organs

Volumn 36, Issue 12, 2013, Pages 845-852

  Morabito, Santo ^a   Pistolesi, Valentina ^a   Tritapepe, Luigi ^b   Vitaliano, Elio ^c   Zeppilli, Laura ^a   Polistena, Francesca ^a   Fiaccadori, Enrico ^d   Pierucci, Alessandro ^a  

^a POLICLINICO UMBERTO I   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c SANDRO PERTINI HOSPITAL   (Italy)

^d UNIVERSITY OF PARMA   (Italy)

Author keywords

Citrate; Continuous veno venous hemofiltration; CRRT; Hypophosphatemia; Phosphate; Regional citrate anticoagulation

Indexed keywords

BODY FLUIDS;

ACID-BASE STATUS; ANTI-COAGULATION; CITRATE; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTINUOUS VENO-VENOI HEMOFILTRATION; HEART SURGERY; HEMOFILTRATION; HYPOPHOSPHATEMIA; REGIONAL CITRATE ANTICOAGULATION; RENAL REPLACEMENT THERAPIES;

ELECTROLYTES;

CALCIUM CHLORIDE; CARBONIC ACID; CITRIC ACID; ELECTROLYTE; FRUCTOSE 1, 6 BISPHOSPHATE; MAGNESIUM SULFATE; PHOSPHATE; PHOSPHORUS; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CELL COUNT; BLOOD FLOW VELOCITY; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTINUOUS HEMOFILTRATION; FEMALE; HUMAN; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; MALE; PH; REGIONAL CITRATE ANTICOAGULATION; RENAL REPLACEMENT THERAPY;

ACID-BASE EQUILIBRIUM; ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION; CARDIAC SURGICAL PROCEDURES; CITRATES; DIALYSIS SOLUTIONS; HEMOFILTRATION; HEMORRHAGE; HUMANS; HYPOPHOSPHATEMIA; MIDDLE AGED; PHOSPHATES; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84891062069     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000283     Document Type: Article

References (24)

1. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med. 2004;30(2):260-265.
2. Kutsogiannis DJ, Gibney RT, Stollery D, Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int. 2005; 67(6):2361-2367.
3. Zhang Z, Hongying N. Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy. Intensive Care Med. 2012;38(1):20-28.
4. Oudemans-van Straaten HM, Ostermann M. Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice. Crit Care. 2012;16(6): 249.
5. Morabito S, Pistolesi V, Pierucci A. Anticoagulazione regionale con citrato: verso un trattamento di prima scelta [Regional citrate anticoagulation: towards a first-choice treatment] (in Italian). G Ital Nefrol. 2012;29(1):14-19.
6. Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl. 2012;2(1):1-138.
7. Davenport A, Tolwani A. Citrate anticoagulation for continuous renal replacement therapy (CRRT) in patients with acute kidney injury admitted to the intensive care unit. NDT Plus. 2009;2(6):439-447.
8. Mariano F, Tedeschi L, Morselli M, Stella M, Triolo G. Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients. Intensive Care Med. 2010;36(10):1735-1743.
9. Tolwani AJ, Prendergast MB, Speer RR, Stofan BS, Wille KM. A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol. 2006;1(1):79-87.
10. Morgera S, Schneider M, Slowinski T, et al. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med. 2009;37(6):2018-2024.
11. Morabito S, Pistolesi V, Tritapepe L, et al. Regional citrate anticoagulation in CVVH: a new protocol combining citrate solution with a phosphate-containing replacement fluid. He-modial Int. 2013;17(2):313-320.
12. Troyanov S, Geadah D, Ghannoum M, Cardinal J, Leblanc M. Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy. Intensive Care Med. 2004;30(8):1662-1665.
13. Santiago MJ, López-Herce J, Urbano J, Bellón JM, del Castillo J, Carrillo A. Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. Kidney Int. 2009;75(3):312-316.
14. Demirjian S, Teo BW, Guzman JA, et al. Hypophosphate-mia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant. 2011;26(11):3508-3514.
15. Broman M, Carlsson O, Friberg H, Wieslander A, Godaly G. Phosphate-containing dialysis solution prevents hypophos-phatemia during continuous renal replacement therapy. Acta Anaesthesiol Scand. 2011;55(1):39-45.
16. Kozik-Jaromin J, Nier V, Heemann U, Kreymann B, Böhler J. Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation. Nephrol Dial Transplant. 2009;24(7):2244-2251.
17. Hetzel GR, Taskaya G, Sucker C, Hennersdorf M, Grabensee B, Schmitz M. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Am J Kidney Dis. 2006;48(5):806-811.
18. Morabito S, Pistolesi V, Tritapepe L, et al. Regional citrate an-ticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution. Crit Care. 2012;16(3): R111.
19. Hetzel GR, Schmitz M, Wissing H, et al. Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial. Nephrol Dial Transplant. 2011;26(1):232-239.
20. Shum H P, Chan KC, Yan WW. Regional citrate anticoagula-tion in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution. Ther Apher Dial. 2012;16(1): 81-86.
21. Chua HR, Baldwin I, Ho L, Collins A, Allsep H, Bellomo R. Biochemical effects of phosphate-containing replacement fluid for continuous venovenous hemofiltration. Blood Purif. 2012;34(3-4):306-312.
22. VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7-20.
23. Bellomo R, Cass A, Cole L, et al; RENAL Replacement Therapy Study Investigators. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361(17):1627-1638.
24. Gupta M, Wadhwa NK, Bukovsky R. Regional citrate antico-agulation for continuous venovenous hemodiafiltration using calcium-containing dialysate. Am J Kidney Dis. 2004;43(1): 67-73.